Inorganic_JJ
lead_NN
activates_VBZ
NF-kappa_NN
B_NN
in_IN
primary_JJ
human_JJ
CD4_NN
+_CC
T_NN
lymphocytes_NNS
._.

Inorganic_JJ
lead_NN
-LRB-_-LRB-
Pb_NN
-RRB-_-RRB-
is_VBZ
a_DT
ubiquitous_JJ
environmental_JJ
contaminant_NN
that_WDT
produces_VBZ
a_DT
variety_NN
of_IN
effects_NNS
on_IN
humoral_JJ
and_CC
cell_NN
mediated_VBD
immune_JJ
responses_NNS
._.

The_DT
underlying_JJ
molecular_JJ
mechanism_NN
for_IN
Pb_NN
's_POS
complex_NN
effects_NNS
on_IN
the_DT
immune_JJ
system_NN
remain_VBP
obscure_JJ
._.

Many_JJ
of_IN
Pb_NN
's_POS
effects_NNS
on_IN
the_DT
immune_JJ
system_NN
could_MD
be_VB
explained_VBN
through_IN
activation_NN
of_IN
the_DT
transcription_NN
factor_NN
,_,
NF-kappa_NN
B_NN
._.

NF-kappa_NN
B_NN
is_VBZ
critical_JJ
for_IN
T_NN
lymphocyte_NN
function_NN
and_CC
is_VBZ
a_DT
strong_JJ
inducer_NN
of_IN
HIV-LTR_NN
activation_NN
._.

We_PRP
demonstrate_VBP
that_IN
Pb_NN
at_IN
physiologically_RB
relevant_JJ
concentrations_NNS
activates_VBZ
NF-kappa_NN
B_NN
in_IN
primary_JJ
human_JJ
CD4_NN
+_CC
T_NN
lymphocytes_NNS
._.

Pb-induced_JJ
activation_NN
of_IN
NF-kappa_NN
B_NN
is_VBZ
blocked_VBN
by_IN
antibodies_NNS
for_IN
p65_NN
and_CC
p50_NN
subunits_NNS
but_CC
not_RB
cRel_NN
,_,
indicating_VBG
that_IN
the_DT
p65_NN
:_:
p50_NN
heterodimer_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
is_VBZ
involved_VBN
._.

Functional_JJ
activation_NN
of_IN
gene_NN
expression_NN
by_IN
Pb_NN
was_VBD
confirmed_VBN
using_VBG
primary_JJ
CD4_NN
+_CC
T_NN
cells_NNS
transfected_VBN
with_IN
an_DT
NF-kappa_NN
B_NN
dependent_JJ
reporter_NN
gene_NN
construct_NN
._.

Pb_NN
did_VBD
not_RB
activate_VB
NF-kappa_NN
B_NN
in_IN
4_CD
different_JJ
T_NN
cell_NN
lines_NNS
,_,
suggesting_VBG
that_IN
lymphoid_JJ
cell_NN
lines_NNS
may_MD
not_RB
be_VB
reliable_JJ
surrogates_NNS
for_IN
the_DT
study_NN
of_IN
transcriptional_JJ
activation_NN
in_IN
human_JJ
T_NN
cells_NNS
._.

These_DT
data_NNS
suggest_VBP
that_IN
NF-kappa_NN
B_NN
may_MD
be_VB
an_DT
important_JJ
molecular_JJ
mediator_NN
of_IN
Pb-induced_JJ
immunotoxicity_NN
._.

